Chuck Royce's SOPH Position Overview
Chuck Royce (via Royce & Associates Lp) currently holds 430,257 shares of SOPHiA GENETICS SA (SOPH) worth $2.01 M, representing 0.02% of the portfolio. First purchased in 2025-Q4, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Chuck Royce has initiated a new position in SOPH, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Chuck Royce's SOPHiA GENETICS (SOPH) Holding Value Over Time
Track share changes against reported price movement
Quarterly SOPHiA GENETICS (SOPH) Trades by Chuck Royce
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +430,257 | New Buy | 430,257 | $4.67 |
Chuck Royce's SOPHiA GENETICS Investment FAQs
Chuck Royce first purchased SOPHiA GENETICS SA (SOPH) in Q4 2025, acquiring 430,257 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Chuck Royce has held SOPHiA GENETICS SA (SOPH) for 1 quarters since Q4 2025.
Chuck Royce's largest addition to SOPHiA GENETICS SA (SOPH) was in Q4 2025, adding 430,257 shares worth $2.01 M.
According to the latest 13F filing for Q4 2025, Chuck Royce's firm, Royce & Associates Lp, owns 430,257 shares of SOPHiA GENETICS SA (SOPH), valued at approximately $2.01 M.
As of the Q4 2025 filing, SOPHiA GENETICS SA (SOPH) represents approximately 0.02% of Chuck Royce's publicly disclosed stock portfolio, making it one of their key holdings.
Chuck Royce's peak holding in SOPHiA GENETICS SA (SOPH) was 430,257 shares, as reported at the end of Q4 2025.